{"filings":[{"id":94443,"accession_number":"0001653477-26-000031","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q1 net sales $258M (+4%), adj. EPS $1.15 beats $1.01; reaffirms guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $258.0M (+4% YoY); GAAP net income $23.4M ($0.65 diluted EPS) vs $29.1M ($0.79) prior year.","Adjusted earnings from cont. ops $41.4M ($1.15 diluted EPS) vs $37.0M ($1.01) in prior year.","Adjusted EBITDA from cont. ops $91.5M, flat YoY; margin 35.5% vs 36.8%.","Completed sale of N. Charleston refinery & Performance Chemicals Industrial Specialties for ~$93M on Jan 1, 2026; Road Markings sale for ~$65M on Apr 15.","Reaffirms full year guidance, adjusted for sale of Road Markings."],"consensus_eps_estimate":null,"consensus_eps_actual":1.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":258000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94442,"accession_number":"0001653477-26-000028","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2026-05-04T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Ingevity shareholders approve 580K share increase to 2025 Omnibus Incentive Plan; all director nominees elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan amendment approved with 31,038,374 for vs 990,650 against, adding 580,000 shares.","Nine director nominees elected; each received >31.7M votes for, with less than 1M withheld.","Advisory say-on-pay passed: 28,593,615 for, 3,435,921 against, 1,443,084 broker non-votes.","Ratification of PwC as auditor for FY2026 approved: 33,358,881 for, 118,571 against.","Quorum of 95.1% (33,498,332 shares) represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94441,"accession_number":"0001653477-26-000021","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ingevity sells Ozark Materials road markings business to PPG for $65M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sold Ozark Materials road markings business to PPG Industries in all-cash deal for ~$65M.","Deal closed simultaneously with signing; proceeds subject to customary adjustments.","Divestiture sharpens portfolio; Ingevity keeps Pavement Technologies business.","Full-year 2026 guidance to be updated with Q1 results, reflecting this sale.","Previously provided 2026 guidance affirmed excluding impact of today's transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106828,"accession_number":"0001104659-26-036423","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Ingevity refinances revolver: reduces commitments to $750M, extends maturity to 2031","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolver reduced from $1B to $750M; maturity extended to five years from March 26, 2026.","Outstanding $512.1M in revolver loans repaid on closing date.","Interest rate margins unchanged: benchmark +1.00%-1.75% or base +0.00%-0.75%.","Customary covenants, representations, and events of default apply; no new material terms.","Guarantors reaffirm obligations under existing loan documents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106827,"accession_number":"0001653477-26-000010","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Ingevity posts FY2025 net loss of $167M on $293M special charges; explores strategic alternatives for APT, Road Markings","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year net sales from continuing ops $1.2B (-3%); net loss $167.1M ($4.61/sh) driven by $293.1M non-cash special charges.","Total adjusted EBITDA from continuing & discont. ops $397.5M (+10% YoY), margin 30.8%; adjusted EBITDA from cont. ops $373.0M (margin 31.9%).","Completed sale of North Charleston crude tall oil refinery assets and Performance Chemicals Industrial Specialties product line.","Operating cash flow $331.2M, free cash flow $273.5M; net leverage improved to 2.6x."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":1167600000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106826,"accession_number":"0001653477-26-000006","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Two founding directors to leave Ingevity board; board reduced from 11 to 9 members","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Daniel F. Sansone and Jean S. Blackwell will not stand for re-election at 2026 Annual Meeting.","Sansone departure due to mandatory retirement age policy; Blackwell after 10 years of service.","Board size decreased from 11 to 9 directors effective after the 2026 Annual Meeting.","Both departures are not due to any disagreement with the company on operations or policies.","Transition is described as normal board refreshment consistent with portfolio optimization."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106825,"accession_number":"0001493152-26-000248","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2026-01-05T23:59:59+00:00","items":["1.01","2.01","7.01","9.01"],"status":"ready","headline":"Ingevity completes sale of CTO refinery and Industrial Specialties for $110M cash plus contingent consideration","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Completed sale of North Charleston CTO refinery and majority of Industrial Specialties to Mainstream Pine Products for $110M cash plus contingent consideration up to $19M.","Transaction announced Sep 2025; closed Jan 1, 2026; press release issued Jan 5.","Amendment excludes non-lignin dispersant products for agricultural chemical applications from asset scope.","Ingevity retains Pavement Technologies and other lignin-based dispersant products, sharpening focus on higher-margin specialty applications.","Strategic move to simplify portfolio, reduce volatility, and enhance cash flow and margin profile."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123137,"accession_number":"0001493152-25-026514","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ingevity CFO Hall to step down May 1, 2026; Platt named successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mary Dean Hall will transition from CFO to advisor role effective May 1, 2026.","Phillip J. Platt, currently SVP Finance & CAO, appointed CFO and executive leadership team member effective same date.","Richard White, President of Performance Chemicals, will shift to special projects on Jan 1, 2026 and depart May 1, 2026.","Reid Clontz appointed SVP, Operations (effective Dec 8, 2025), adding supply chain, procurement, safety.","Changes announced as Ingevity completes strategic portfolio review."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123136,"accession_number":"0001493152-25-026513","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ingevity explores strategic alternatives for APT segment and Road Markings; completes $30M+ buybacks in Q4","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed portfolio review; exploring sale of Advanced Polymer Technologies segment and Performance Chemicals Road Markings business.","Completed over $30 million in stock repurchases during Q4 2025 as part of capital return effort.","CEO states APT and Road Markings are not fully aligned with Ingevity's core competencies or strategic direction.","Hosting a Strategic Portfolio Update webcast on Dec 8, 2025 at 9:00 a.m. Eastern.","No assurance that any transaction will result from the strategic review process."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123135,"accession_number":"0001653477-25-000133","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ingevity provides recast financials reflecting divested businesses as discontinued operations","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Divestiture of industrial specialties line and North Charleston CTO Refinery expected to close by early 2026.","Unaudited recast statements for 2023, 2024, and quarterly periods in 2024 and 2025 now reflect these as discontinued operations.","Sale represents a strategic shift that will have a major effect on Ingevity's operations and results.","Amounts are preliminary and subject to change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123134,"accession_number":"0001653477-25-000124","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q3 total net sales $362.1M (-4% YoY); adj EBITDA $121.2M (+14%); revises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $43.5M, EPS $1.18; continuing ops net income $40.8M, EPS $1.10.","Total adjusted EBITDA $121.2M (+14% YoY); margin improved to 33.5%.","Announced sale of majority of Industrial Specialties and N. Charleston refinery for $110M; close by early 2026; reported as discontinued ops.","Operating cash flow $129.7M, free cash flow $117.8M; $25M share repurchases; net leverage 2.7x.","Revised FY guidance: total net sales $1.25B-$1.35B, total adj EBITDA $390M-$405M."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":912500000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123133,"accession_number":"0001653477-25-000119","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ingevity appoints Ruth Castillo as Senior VP and President of Performance Materials","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ruth Castillo appointed SVP and President, Performance Materials, effective Nov. 10, 2025.","Castillo brings over 25 years of chemicals and materials experience, most recently VP Global Chemicals at Avantor.","She will join Ingevity's executive leadership team and report to CEO Dave Li.","Castillo will lead the activated carbon segment to accelerate innovation and strategic growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139813,"accession_number":"0001493152-25-012603","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-09-04T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Ingevity agrees to sell CTO refinery and Industrial Specialties to Mainstream Pine Products for $110M cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All-cash deal: $110M at closing plus up to $19M contingent consideration; expected close by early 2026.","2025 revenue from sold assets ~$130M with low-to-mid single-digit EBITDA margins; to be reported as discontinued operations.","Ingevity affirms FY2025 guidance (ex-discontinued ops): sales $1.25-1.40B, adj. EBITDA $390-415M.","Supply agreement for Road Technologies products; toll-manufacturing and reciprocal plant operating agreements with Mainstream.","Transaction reduces portfolio volatility, strengthens margin/cash flow; proceeds to accelerate deleveraging."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139812,"accession_number":"0001653477-25-000104","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity posts Q2 net loss of $146.5M on $183.8M goodwill impairment; adjusted EPS up 38% to $1.39","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $365.1M, down 7% YoY, led by lower Performance Chemicals volumes.","Net loss $146.5M ($4.02 diluted loss) includes $183.8M non-cash goodwill impairment.","Adjusted earnings $51.1M (+39%); adjusted diluted EPS $1.39 (+38%).","Adjusted EBITDA $110.0M (+9%), margin improved to 30.1% on repositioning actions.","Raises low-end of adjusted EBITDA guidance to $390–$415M; sales guidance reaffirmed at $1.25–$1.40B."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":649100000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139811,"accession_number":"0001641172-25-017264","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ingevity EVP & President of Performance Materials Ed Woodcock departs after 37 years","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Woodcock left July 1, 2025; company begins search for successor.","Interim management: Andrew Fox (VP, Performance Materials & Asia-Pacific president) and Jonathan MacIver (VP global commercial).","Severance includes lump sum cash, monthly base+target over 12 months, $500K incentive, and prorated equity vesting.","Full-year guidance reaffirmed; no change from prior disclosure.","Woodcock's separation follows a Letter Agreement with non-compete and non-solicitation covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157401,"accession_number":"0001653477-25-000062","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q1: adjusted EBITDA $91.3M (+23%); sales $284M (-17%); FY guidance revised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $284.0M, down 17% YoY, due to Performance Chemicals repositioning and exit of lower-margin markets.","Net income $20.5M, diluted EPS $0.56; adjusted earnings $36.4M, adjusted EPS $0.99.","Adjusted EBITDA $91.3M (+23% YoY); margin improved to 32.1%.","Revised FY2025 guidance: sales $1.25B-$1.40B, adjusted EBITDA $380M-$415M, citing tariff uncertainty and auto production declines.","Operating cash flow $25.4M; free cash flow $15.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":284000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157400,"accession_number":"0001653477-25-000058","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Ingevity expands board to 11; elects new CEO Li and Segal; Hoechner named Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased from 9 to 11; David H. Li (President & CEO) and F. David Segal elected directors.","Bruce D. Hoechner elected as Board Chair for two-year term ending at 2027 annual meeting.","Stockholders approved 2025 Omnibus Incentive Plan with ~30.0M for, 2.6M against.","All nine director nominees elected; say-on-pay passed with 29.6M for, 2.9M against.","Segal appointed per cooperation agreement with Vision One Fund dated March 30, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175771,"accession_number":"0001140361-25-011158","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Ingevity settles proxy contest with Vision One; appoints F. David Segal to board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cooperation agreement appoints F. David Segal to board and audit committee within one day of 2025 annual meeting.","Board size capped at 11 directors until the expiration date (2026 annual meeting nomination window).","Vision One withdraws its nominees for 2025 annual meeting and agrees to standstill and voting commitments.","Vision One must maintain at least 417,178 shares to retain replacement director rights.","Company to amend audit committee charter to review capital allocation policies within five days of Segal's appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175770,"accession_number":"0001140361-25-007884","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ingevity appoints David H. Li as CEO; $1.1M base salary, $5M one-time equity award","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David H. Li appointed President and CEO effective April 7, 2025, succeeding interim CEO Luis Fernandez-Moreno who remains on board.","Mr. Li has over 25 years specialty materials experience, most recently CEO of CMC Materials sold to Entegris in 2022.","Compensation: base salary $1.1M, annual cash target 120% of base, LTIP target 500% of base.","One-time equity award of $5M: $2M PSUs (three-year performance), $1M RSUs (four-year vest), $2M options.","Mr. Li expected to join board after 2025 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175769,"accession_number":"0001653477-25-000011","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q4 net sales down 20% YoY to $298.8M; full-year net loss $430.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $298.8M (-20% YoY); adjusted EBITDA $80.6M (margin 27.0%); net income $16.6M includes $23.4M restructuring charges.","Full-year net sales $1.4B (-17% YoY); net loss $430.3M on $688M pre-tax charges in Performance Chemicals; adjusted EPS $3.51.","2025 guidance: sales $1.3B-$1.4B, adjusted EBITDA $400M-$415M, free cash flow $220M-$260M.","In January 2025, began exploring strategic alternatives for Performance Chemicals Industrial Specialties line and North Charleston CTO refinery.","Q4 operating cash flow $64.5M included final $50M termination fee payment from a long-term CTO supply agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":-11.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":1406400000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175768,"accession_number":"0001653477-25-000005","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2025-01-16T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Ingevity explores sale of Industrial Specialties line; prelim FY2024 sales $1.40B, EBITDA ~$360M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exploring strategic alternatives for Performance Chemicals Industrial Specialties product line, including potential divestiture of North Charleston CTO refinery.","Preliminary FY2024 net sales ~$1.40B; Adjusted EBITDA ~$360M (high end of prior guidance); free cash flow >$40M (significantly above guidance).","2025 Adjusted EBITDA expected slightly above $400M, excluding any impact from strategic alternatives review.","Management evaluating additional actions to maximize shareholder value; sequential segment EBITDA margin improvement in H2 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192701,"accession_number":"0001653477-24-000103","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-12-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ingevity elects Ashland CFO J. Kevin Willis to its board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Willis is SVP and CFO of Ashland Inc. (NYSE:ASH), with 37 years of chemical-industry financial experience.","Board expands to nine members (eight independent); Willis fills newly created vacancy.","Willis will serve on the Audit and Sustainability and Safety committees.","Term runs until the 2025 Annual Meeting; compensation pro-rated per non-employee director practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192700,"accession_number":"0001653477-24-000096","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q3 net loss $107.2M; sales down 16% YoY; affirms FY adjusted EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $376.9M, down 16% YoY, primarily due to Performance Chemicals repositioning.","Net loss $107.2M ($2.95 diluted EPS) includes $86.9M restructuring charges and $100M contract termination fees.","Adjusted EPS $1.10; adjusted EBITDA $106.4M (28.2% margin).","Full-year guidance: sales $1.40-$1.50B, adjusted EBITDA $350-$360M.","Operating cash flow $46.5M, free cash flow $28.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":-12.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":1107600000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192699,"accession_number":"0001653477-24-000093","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-10-25T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Ingevity amends bylaws to revise stockholder nomination and proposal procedures","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board adopted Fourth Amended and Restated Bylaws effective October 22, 2024.","Updates procedural and disclosure requirements for stockholder nominations and proposals.","Requires additional information, disclosures, and representations from proposing stockholders and nominees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192698,"accession_number":"0001493152-24-039288","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-10-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ingevity CEO John Fortson departs; board member Luis Fernandez-Moreno named interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Fortson resigned as President, CEO, and board member effective October 2, 2024.","Board member Luis Fernandez-Moreno appointed interim President and CEO; search for permanent CEO underway.","Interim CEO Fernandez-Moreno receives $3M annual salary and $1M one-time RSU award vesting over one year.","Fortson eligible for severance per prior agreement subject to confidentiality and non-compete covenants.","Third-quarter 2024 earnings scheduled for release after market close on October 30, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209146,"accession_number":"0001653477-24-000080","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q2 net loss $283.7M on goodwill impairment; guides FY sales $1.40-1.50B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $390.6M, down 19% YoY; net loss of $283.7M ($7.81 diluted EPS) due to Performance Chemicals goodwill impairment.","Adjusted earnings $36.8M, adjusted diluted EPS $1.01; adjusted EBITDA $101.3M (25.9% margin).","Terminated a long-term crude tall oil supply contract; closing Crossett, AR facility for cost savings.","Revised FY 2024 guidance: sales $1.40-1.50B (from prior range) and adjusted EBITDA $350-360M.","Operating cash flow $29.7M; free cash flow $11.6M in Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":-9.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":730700000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209145,"accession_number":"0001653477-24-000078","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.05","7.01","9.01"],"status":"ready","headline":"Ingevity to close Crossett, AR plant; expects $30-35M annual savings from restructuring","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plans to close Crossett plant in August 2024; consolidate oleo refining to North Charleston, SC facility.","Expects net operational savings of $20M-$25M/yr from plant closure plus ~$10M/yr from corporate cost reductions.","Total restructuring charges estimated at ~$100M, including ~$65M non-cash asset charges and ~$35M cash costs.","Majority of non-cash charges and 50-60% of cash charges expected recognized by H1 2025.","Company cites slow industrial recovery in oleo markets as driver; full savings expected in 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209144,"accession_number":"0001653477-24-000073","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["1.01","1.02","7.01","9.01"],"status":"ready","headline":"Ingevity pays $100M to terminate crude tall oil supply agreement with Georgia-Pacific","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Paid $50M on July 1, 2024; second $50M installment due Oct 15, 2024 to terminate 20-year CTO supply pact.","Supply agreement suspended July 1; termination upon full payment and satisfaction of June purchase obligations.","Company evaluating restructuring of Performance Chemicals segment in 2024 to focus on specialty chemicals markets.","Ingevity must purchase up to ~12,760 tons of crude tall oil in June/July 2024 as part of termination terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209143,"accession_number":"0001653477-24-000068","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ingevity EVP & General Counsel Stacy Cozad resigns; Ryan Fisher appointed successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Cozad resigned effective June 26, 2024; Fisher appointed SVP, General Counsel & Secretary.","Transition Agreement provides $673,741 cash payment for forfeited unvested RSUs.","Cozad remains bound by confidentiality, non-compete, and non-solicitation covenants.","Cozad will cooperate post-employment on as-needed basis; company reimburses expenses.","Fisher previously served as VP, Deputy General Counsel and Chief Compliance Officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227023,"accession_number":"0001653477-24-000055","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q1 2024 net loss of $56M, sales down 13%; reiterates full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $340.1M, down 13% YoY; net loss $56.0M ($1.54 diluted EPS loss).","Adjusted earnings $19.1M, adjusted EPS $0.52; adjusted EBITDA $76.9M (22.6% margin).","Operating cash flow negative $12.1M, free cash flow negative $28.7M, including $19.8M cash losses on CTO resales.","Realized $20M cost savings in Q1; targeting $65-75M for full year 2024.","Full-year 2024 guidance reaffirmed: sales $1.40B-$1.55B, adjusted EBITDA $365M-$390M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":340100000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227022,"accession_number":"0001653477-24-000042","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Ingevity shareholders elect all nine directors, approve say-on-pay and charter amendment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All nine director nominees elected with 31.5–32.1 million votes for; broker non-votes of 1.78 million shares.","Advisory say-on-pay approved with 31.5 million for (96.6% of votes cast excluding broker non-votes).","Ratification of PwC as independent auditor for 2024 passed with 34.1 million for (99.6% of votes cast).","Amendment for officer exculpation (officer liability) approved with 29.1 million for (89.7% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":245948,"accession_number":"0001653477-24-000033","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-03-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director William J. Slocum resigns from Ingevity board effective March 13, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Resignation not due to any disagreement with the company on operations, policies, or practices.","Board size to decrease to 9 effective at the 2024 Annual Meeting as previously disclosed in proxy statement.","Slocum's departure is part of a planned board reduction; no replacement announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":245947,"accession_number":"0001653477-24-000006","cik":1653477,"company_name":"Ingevity Corp","ticker":"NGVT","form_type":"8-K","filed_at":"2024-02-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ingevity Q4 net loss of $116.8M includes $107.5M restructuring; FY2024 sales guidance $1.40-1.55B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $371.7M (-3.1% YoY); net loss $116.8M, diluted loss per share $3.23.","Restructuring charges of $107.5M driven by shutdown of DeRidder, LA CTO refinery completed early Feb 2024.","Adjusted EPS $0.21; adjusted EBITDA $61.8M (16.6% margin).","Full-year 2023 net sales $1.69B (+1.4% YoY); net loss $5.4M; adjusted EPS $3.94.","FY2024 guidance: sales $1.40-1.55B; adjusted EBITDA $365-390M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":1692100000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2397855778.7157984,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}